Evidence map›Paper›PMID 19077434›Full record

ArticleHuman heredity2009

Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate.

Barbara Kremeyer, Jenny García, Hanna Kymäläinen, Naomi Wratten, Gabriel Restrepo, Carlos Palacio, Ana Lucía Miranda, Carlos López, Margarita Restrepo, Gabriel Bedoya and 4 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Human heredity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. NOS1AP regulates dendrite patterning of hippocampal neurons through a carboxypeptidase E-mediated pathway.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

14 authors at 5 institutions in 5 countries.

Barbara KremeyerThe Galton Laboratory, Department of Biology, University College London, London, UK.
Jenny García
Hanna Kymäläinen
Naomi Wratten
Gabriel Restrepo
Carlos Palacio
Ana Lucía Miranda
Carlos López
Margarita Restrepo
Gabriel Bedoya
Linda M Brzustowicz
Jorge Ospina-Duque
María Patricia Arbeláez
Andrés Ruiz-Linares
Universidad de Antioquia · COClínica de Psiquiatria Psiquimei · BRUniversity College London · GBRutgers, The State University of New Jersey · USUniversity Hospital, Newark · US

Funding

Molecular Genetics of Schizophrenia SusceptibilityR01MH062440 · NIMH · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI BRZUSTOWICZ, LINDA M · 2001 to 2008
$3.4M
NIMH NIH HHS R01 MH062440NIMH NIH HHS R01 MH62440
6 · The paper itself

Abstract

BACKGROUND/

aimsRecent studies have implicated a region on chromosome 1q21-23, including the NOS1AP gene, in susceptibility to schizophrenia. However, replication studies have been inconsistent, a fact that could partly relate to the marked psychopathological heterogeneity of schizophrenia. The aim of this study is to evaluate association of polymorphisms in the NOS1AP gene region to schizophrenia, in patients from a South American population isolate, and to assess if these variants are associated with specific clinical dimensions of the disorder.

methodsWe genotyped 24 densely spaced SNPs in the NOS1AP gene region in a schizophrenia trio sample. The transmission disequilibrium test (TDT) was applied to single marker and haplotype data. Association to clinical dimensions (identified by factor analysis) was evaluated using a quantitative transmission disequilibrium test (QTDT).

resultsWe found significant association between eight SNPs in the NOS1AP gene region to schizophrenia (minimum p value = 0.004). The QTDT analysis of clinical dimensions revealed an association to a dimension consisting mainly of negative symptoms (minimum p value 0.001).

conclusionsOur findings are consistent with a role for NOS1AP in susceptibility to schizophrenia, especially for the 'negative syndrome' of the disorder.

Indexed as

Adaptor Proteins, Signal TransducingAdultBase SequenceFactor Analysis, StatisticalFemaleGenetic MarkersGenetic Predisposition to DiseaseGenome-Wide Association StudyHaplotypesHumansLinkage DisequilibriumMaleMiddle AgedOdds RatioPolymorphism, Single NucleotideSchizophreniaAdaptor Proteins, Signal TransducingGenetic MarkersNOS1AP protein, human

Identifiers

PMID19077434
PMCPMC2868919
OpenAlexW1973691474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.